Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-012796
Filing Date
2022-12-19
Accepted
2022-12-19 21:15:10
Documents
1
Period of Report
2022-12-16

Document Format Files

Seq Description Document Type Size
1 form4-12202022_021201.html 4  
1 form4-12202022_021201.xml 4 3716
  Complete submission text file 0001415889-22-012796.txt   5049
Mailing Address
Business Address
DIXON WENDY L (Reporting) CIK: 0001202283 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 221472714

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)